|
Volumn 26, Issue 4, 2008, Pages 362-
|
Four rebuffs for Cabilly.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
DRUG INDUSTRY;
GOVERNMENT REGULATION;
LEGAL ASPECT;
LICENSING;
NOTE;
ORGANIZATION AND MANAGEMENT;
PATENT;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
CALIFORNIA;
DRUG INDUSTRY;
GOVERNMENT REGULATION;
LICENSURE;
OWNERSHIP;
PATENTS AS TOPIC;
UNITED STATES;
|
EID: 42949088529
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0408-362a Document Type: Note |
Times cited : (1)
|
References (0)
|